You are here

  • Home
  • Archive
  • Volume 82, Issue Suppl 1
  • POS1120 IMPACT OF BASELINE CRP LEVEL ON SECUKINUMAB (SEC) RETENTION IN AXIAL SPONDYLOARTHRITIS (AXSPA): RESULTS OF THE FRENCH RETROSPECTIVE STUDY FORSYA

Article info

Article menu

Download PDFPDF

Scientific Abstracts
Poster View
Spondyloarthritis - treatment
POS1120 IMPACT OF BASELINE CRP LEVEL ON SECUKINUMAB (SEC) RETENTION IN AXIAL SPONDYLOARTHRITIS (AXSPA): RESULTS OF THE FRENCH RETROSPECTIVE STUDY FORSYA
Free

Authors

Citation

Goupille P, Dougados M, Lardy-Cléaud A, et al
POS1120 IMPACT OF BASELINE CRP LEVEL ON SECUKINUMAB (SEC) RETENTION IN AXIAL SPONDYLOARTHRITIS (AXSPA): RESULTS OF THE FRENCH RETROSPECTIVE STUDY FORSYA
Annals of the Rheumatic Diseases 2023;82:886-887.

Publication history

  • First published May 30, 2023.
Online issue publication 
August 23, 2023

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.